HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Odegaard Selected Research

Ulcer

1/2001Cost effectiveness of Becaplermin in the treatment of diabetic foot ulcers in four European countries.
11/2000The cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (Regranex): a core model with an application using Swedish cost data.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Odegaard Research Topics

Disease

2Ulcer
01/2001 - 11/2000
2Wounds and Injuries (Trauma)
01/2001 - 11/2000
1Diabetic Foot
01/2001
1Gangrene
11/2000

Drug/Important Bio-Agent (IBA)

2Becaplermin (PDGF-BB)FDA Link
01/2001 - 11/2000

Therapy/Procedure

2Surgical Amputation (Amputations)
01/2001 - 11/2000